Compare SOPH & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOPH | AHG |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | Switzerland | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.4M | 812.8M |
| IPO Year | 2021 | N/A |
| Metric | SOPH | AHG |
|---|---|---|
| Price | $4.61 | $1.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 101.2K | 5.4K |
| Earning Date | 11-04-2025 | 12-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $73,297,000.00 | $14,777,798.00 |
| Revenue This Year | $18.32 | N/A |
| Revenue Next Year | $15.61 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 13.66 | ★ 512.09 |
| 52 Week Low | $2.58 | $0.83 |
| 52 Week High | $5.30 | $2.35 |
| Indicator | SOPH | AHG |
|---|---|---|
| Relative Strength Index (RSI) | 49.43 | 44.56 |
| Support Level | $4.63 | $1.21 |
| Resistance Level | $4.95 | $1.39 |
| Average True Range (ATR) | 0.27 | 0.09 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 15.13 | 34.72 |
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.